Business Context and Reporting Period
This Form 8-K is a current report filed by Heatwurx, Inc. on November 8, 2014, regarding events occurring on November 6, 2014. The filing addresses a change in the company's senior financial leadership.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The only financial data disclosed relates to executive compensation.
- Interim CFO Compensation: $9,000 per month plus travel expenses.
Material Changes
Effective November 6, 2014, the company appointed Heather Kearns as Interim Chief Financial Officer (CFO). This appointment replaces Alex Kramer, who held the position since May 27, 2014, and departed on October 25, 2014. Prior to Ms. Kearns' appointment, the company's President and CEO, Dave Dworsky, briefly served as the Principal Financial and Accounting Officer. Mr. Dworsky ceased serving in that capacity upon Ms. Kearns' appointment.
Outlook and Management Commentary
Ms. Kearns is expected to serve as Interim CFO until at least March 31, 2015. The filing notes that Ms. Kearns previously served as Controller for Heatwurx, Inc. from March 2013 to June 2014 and has been working as an independent contractor for the company since June 2014. No specific business outlook, risks, or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the reason for the departure of the previous CFO, Alex Kramer.
- Confirm the duration of the interim CFO arrangement and plans for a permanent replacement.
- Review subsequent filings for any financial statements or disclosures that may have been delayed due to the leadership transition.
- Note the discrepancy between the company name in the metadata (Processa Pharmaceuticals, Inc.) and the registrant name in the filing (Heatwurx, Inc.).